Cargando…
Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa
Hypercalcemia secondary to malignancy is rare in children and the majority is caused by tumor-produced parathyroid hormone-related protein (PTHrP). We report a case of hypercalcemia refractory to bisphosphonate and corticosteroid therapy, but responsive to denosumab. A 17-year-old boy with epidermol...
Autores principales: | Giri, Dinesh, Ramakrishnan, Renuka, Hayden, James, Brook, Lynda, Das, Urmi, Mughal, M. Zulf, Selby, Peter, Dharmaraj, Poonam, Senniappan, Senthil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649725/ https://www.ncbi.nlm.nih.gov/pubmed/29147430 http://dx.doi.org/10.14740/wjon907w |
Ejemplares similares
-
Testosterone Therapy Improves the First Year Height Velocity in Adolescent Boys with Constitutional Delay of Growth and Puberty
por: Giri, Dinesh, et al.
Publicado: (2017) -
Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study
por: Apperley, Louise, et al.
Publicado: (2018) -
Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study
por: Apperley, Louise Jayne, et al.
Publicado: (2020) -
Inherited epidermolysis bullosa
por: Fine, Jo-David
Publicado: (2010) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018)